Dilated Cardiomyopathy (DCM) is a serious heart condition characterized by the enlargement of the heart chambers, specifically the left ventricle. This disorder weakens the heart muscle, impairing its ability to pump blood efficiently. As a result, the heart becomes dilated and weakened, leading to a decrease in the overall pumping function. DCM can be caused by a variety of factors, including genetic predisposition, viral infections, certain medications, and exposure to toxins. The symptoms of DCM often include fatigue, shortness of breath, swelling in the legs, and an irregular heartbeat. Timely identification plays a pivotal role in effectively managing the condition and averting potential complications.. Treatment options may include medications, lifestyle changes, and in severe cases, heart transplant. Regular medical monitoring and adherence to a heart-healthy lifestyle are essential for individuals living with Dilated Cardiomyopathy.
Title : Surgical fetal stem cells implantation in heart failure patients long term results at 14 years
Federico Benetti, Benetti Foundation, Argentina
Title : Exploring new biomarkers of cardiomyopathy
Shuping Zhong, University of Southern California, United States
Title : The development of human relaxin-2 for heart failure with preserved ejection fraction, HFpEF
Thomas Bernd Dschietzig, Relaxera GmbH & Co. KG, Germany
Title : Cancer and cardiovascular diseases: Common pathogenesis mechanisms and risk factors
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation
Title : Pulse field ablation for atrial fibrillation complications: What do we know yet
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : Lipoprotein (a): The hidden cardiovascular risk
Syed Raza, Awali Hospital, Bahrain